In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Two years after completing its HKD8.73bn IPO, Sinopharm Group Co. Ltd., China’s largest drug distributor, has netted HKD3.4bn ($436mm) in a secondary placement of 138mm H shares at HKD25 on the Hong Kong Stock Exchange. Proceeds will help fund the many acquisitions the company plans over the next two years to expand its distribution network.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?